Healthcare provider profile · identity verified

Kurt Cook, M.D.

Family Practice · DENVER, CO · NPI 1417010398

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	375	43
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	176	19
Oxycodone Hcl	Oxycodone Hcl	173	16
Atorvastatin Calcium	Atorvastatin Calcium	122	45
Amlodipine Besylate	Amlodipine Besylate	110	36
Alprazolam	Alprazolam	107	11
Lisinopril	Lisinopril	107	39
Omeprazole	Omeprazole	97	30
Tramadol Hcl	Tramadol Hcl	86	12
Albuterol Sulfate Hfa	Albuterol Sulfate	82	26
Zolpidem Tartrate	Zolpidem Tartrate	80	13
Gabapentin	Gabapentin	72	18
Morphine Sulfate Er	Morphine Sulfate	72	suppressed
Losartan Potassium	Losartan Potassium	66	21
Diclofenac Sodium	Diclofenac Sodium	62	20
Fluticasone Propionate	Fluticasone Propionate	57	20
Metformin Hcl	Metformin Hcl	56	21
Tamsulosin Hcl	Tamsulosin Hcl	53	18
Sertraline Hcl	Sertraline Hcl	48	18
Hydrochlorothiazide	Hydrochlorothiazide	46	12
Jardiance	Empagliflozin	46	18
Levothyroxine Sodium	Levothyroxine Sodium	44	13
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	40	suppressed
Metformin Hcl Er	Metformin Hcl	40	15
Semglee (Yfgn) Pen	Insulin Glargine-Yfgn	40	suppressed
Furosemide	Furosemide	39	13
Rosuvastatin Calcium	Rosuvastatin Calcium	38	12
Trazodone Hcl	Trazodone Hcl	38	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	36	suppressed
Diazepam	Diazepam	36	suppressed
Potassium Chloride	Potassium Chloride	36	suppressed
Clonazepam	Clonazepam	35	suppressed
Famotidine	Famotidine	34	12
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	34	11
Trulicity	Dulaglutide	34	11
Fluoxetine Hcl	Fluoxetine Hcl	33	suppressed
Mirtazapine	Mirtazapine	33	14
Methocarbamol	Methocarbamol	32	suppressed
Amoxicillin	Amoxicillin	30	11
Lorazepam	Lorazepam	30	suppressed
Prednisone	Prednisone	30	suppressed
Ibuprofen	Ibuprofen	29	13
Doxycycline Hyclate	Doxycycline Hyclate	28	suppressed
Naproxen	Naproxen	28	suppressed
Pregabalin	Pregabalin	27	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	26	19
Xarelto	Rivaroxaban	26	suppressed
Cephalexin	Cephalexin	25	suppressed
Meloxicam	Meloxicam	25	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	25	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	24	suppressed
Simvastatin	Simvastatin	24	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	21	12
Lidocaine	Lidocaine	21	suppressed
Ondansetron Odt	Ondansetron	20	suppressed
Ozempic	Semaglutide	20	suppressed
Tizanidine Hcl	Tizanidine Hcl	20	suppressed
Spiriva Handihaler	Tiotropium Bromide	19	suppressed
Buspirone Hcl	Buspirone Hcl	17	suppressed
Baclofen	Baclofen	16	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	16	suppressed
Sure Comfort Pen Needle	Pen Needle, Diabetic	16	suppressed
Azithromycin	Azithromycin	15	12
Clorazepate Dipotassium	Clorazepate Dipotassium	15	suppressed
Glipizide Er	Glipizide	15	suppressed
Fentanyl	Fentanyl	14	suppressed
Methadone Hcl	Methadone Hcl	14	suppressed
Naloxone Hcl	Naloxone Hcl	14	14
Alendronate Sodium	Alendronate Sodium	13	suppressed
Clotrimazole	Clotrimazole	13	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	13	suppressed
Finasteride	Finasteride	13	suppressed
Irbesartan	Irbesartan	13	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	13	suppressed
Carvedilol	Carvedilol	12	suppressed
Duloxetine Hcl	Duloxetine Hcl	12	suppressed
Glipizide	Glipizide	12	suppressed
Ondansetron Hcl	Ondansetron Hcl	12	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	12	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	11	suppressed
Propranolol Hcl	Propranolol Hcl	11	suppressed
Ventolin Hfa	Albuterol Sulfate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error